Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease

European Journal of Health Economics

Volumn 17, Issue 3, 2016, Pages 269-285

  Berndt, Nadine ^a,b   Bolman, Catherine ^a   Lechner, Lilian ^a   Max, Wendy ^c   Mudde, Aart ^a   de Vries, Hein ^d   Evers, Silvia ^d,e  

^a OPEN UNIVERSITY OF THE NETHERLANDS   (Netherlands)

^b Le Gouvernement du Grand Duché de Luxembourg   (Luxembourg)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

Author keywords

Coronary heart disease; Economic evaluation; Face to face counseling; Quality of life; Smoking cessation; Telephone counseling

Indexed keywords

NICOTINE PATCH; NICOTINE GUM;

ADULT; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FACE TO FACE COUNSELING; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; ICD-10; INTENSIVE CARE UNIT; INTENTION TO TREAT ANALYSIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SMOKING CESSATION; TELEPHONE; TELEPHONE COUNSELING; TOBACCO DEPENDENCE; WARD; AGED; CORONARY DISEASE; COST BENEFIT ANALYSIS; COUNSELING; ECONOMICS; PROCEDURES; SMOKING; SOCIOECONOMICS; STATISTICAL MODEL;

ADULT; AGED; CORONARY DISEASE; COST-BENEFIT ANALYSIS; COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMETRIC; NETHERLANDS; QUALITY-ADJUSTED LIFE YEARS; SMOKING; SMOKING CESSATION; SOCIOECONOMIC FACTORS; TELEPHONE; TOBACCO USE CESSATION PRODUCTS;

EID: 84925398065     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-015-0677-x     Document Type: Article

References (85)

1. Critchley, J.A., Capewell, S.: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 290(1), 86–97 (2003)
2. Gerber, Y., Rosen, L.J., Goldbourt, U., Benyamini, Y., Drory, Y.: Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study. J. Am. Coll. Cardiol. 54(25), 2382–2387 (2009)
3. Mohiuddin, S.M., Mooss, A.N., Hunter, C.B., Grollmes, T.L., Cloutier, D.A., Hilleman, D.E.: Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 131(2), 446–452 (2007)
4. Van Spall, H.G., Chong, A., Tu, J.V.: Inpatient smoking-cessation counseling and all-cause mortality in patients with acute myocardial infarction. Am. Heart J. 154(2), 213–220 (2007)
5. Max, W., Rice, D.P., Sung, H.Y., Zhang, X., Miller, L.: The economic burden of smoking in California. Tob. Control 13(3), 264–267 (2004)
6. Froelicher, E.S., Sohn, M., Max, W., Bacchetti, P.: Women’s initiative for nonsmoking-VII: evaluation of health service utilization and costs among women smokers with cardiovascular disease. J. Cardiopulm. Rehabil. 24(4), 218–228 (2004)
7. Lightwood, J.M., Glantz, S.A.: Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 96(4), 1089–1096 (1997)
8. Barth, J., Critchley, J., Bengel, J.: Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database Syst. Rev. 1, CD006886 (2008). doi:10.1002/14651858.CD006886
9. Bolman, C., de Vries, H., van Breukelen, G.: A minimal-contact intervention for cardiac inpatients: long-term effects on smoking cessation. Prev. Med. 35(2), 181–192 (2002)
10. Rice, V.H., Stead, L.: Nursing intervention and smoking cessation: meta-analysis update. Heart Lung 35(3), 147–163 (2006)
11. Rigotti, N.A., Munafo, M.R., Stead, L.F.: Smoking cessation interventions for hospitalized smokers: a systematic review. Arch. Intern. Med. 168(18), 1950–1960 (2008)
12. Shishani, K., Sohn, M., Okada, A., Froelicher, E.S.: Nursing interventions in tobacco-dependent patients with cardiovascular diseases. Annu. Rev. Nurs. Res. 27, 221–242 (2009)
13. Hennrikus, D.J., Lando, H.A., McCarty, M.C., Klevan, D., Holtan, N., Huebsch, J.A., et al.: The TEAM project: the effectiveness of smoking cessation. Prev. Med. 40(3), 249–258 (2005)
14. Kotz, D., van Litsenburg, W., van Duurling, R., van Schayck, C.P., Wesseling, G.J.: Smoking cessation treatment by Dutch respiratory nurses: reported practice, attitudes and perceived effectiveness. Patient Educ. Couns. 70(1), 40–49 (2008)
15. Sarna, L., Bialous, S.A., Wells, M., Kotlerman, J., Wewers, M.E., Froelicher, E.S.: Frequency of nurses smoking cessation interventions: report from a national survey. J. Clin. Nurs. 18(14), 2066–2077 (2009)
16. Segaar, D., Bolman, C., Willemsen, M.C., Vries, H.: Determinants of adoption of cognitive behavioral interventions in a hospital setting: example of a minimal-contact smoking cessation intervention for cardiology wards. Patient Educ. Couns. 61(2), 262–271 (2006)
17. Wetta-Hall, R., Ablah, E., Frazier, L.M., Molgaard, C., Berry, M., Good, M.: Factors influencing nurses’ smoking cessation assessment and counseling practices. J. Addict. Nurs. 16(3), 131–135 (2005)
18. Dutch Institute for Health Care (Centraal BegeleidingsOrgaan (CBO)): Guideline treatment of tobacco dependence. Van Zuiden Communications, Alphen aan den Rijn (2009)
19. Fiore, M.C., Jaén, C.R., Baker, T.B., Bailey, W.C., Benowitz, N.L., Curry, S.J., et al. Treating tobacco use and dependence: 2008 update. US Department of Health and Human Services, Rockville. http://bphc.hrsa.gov/buckets/treatingtobacco.pdf (2008). Accessed 13 Sept 2013
20. Berndt, N.C., Bolman, C., de Vries, H., Segaar, D., van Boven, I., Lechner, L.: Smoking cessation treatment practices: recommendations for improved adoption on cardiology wards. J. Cardiovasc. Nurs. 28(1), 35–47 (2011)
21. Orleans, C.T., Woolf, S.H., Rothemich, S.F., Marks, J.S., Isham, G.J.: The top priority: building a better system for tobacco-cessation counseling. Am. J. Prev. Med. 31(1), 103–106 (2006)
22. Lancaster, T., Stead, L.F.: Individual behavioural counselling for smoking cessation. Cochrane Database Syst. Rev. (2), CD001292 (2005). doi:10.1002/14651858.CD001292.pub2
23. Stead, L.F., Perera, R., Lancaster, T.: Telephone counselling for smoking cessation. Cochrane Database Syst. Rev. 3, CD002850 (2006). doi:10.1002/14651858.CD002850.pub2
24. Froelicher, E.S., Miller, N.H., Christopherson, D.J., Martin, K., Parker, K.M., Amonetti, M., et al.: High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: the women’s initiative for nonsmoking (WINS). Circulation 109(5), 587–593 (2004)
25. Reid, R.D., Pipe, A.L., Quinlan, B., Oda, J.: Interactive voice response telephony to promote smoking cessation in patients with heart disease: a pilot study. Patient Educ. Couns. 66(3), 319–326 (2007)
26. Smith, P.M., Burgess, E.: Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial. CMAJ 180(13), 1297–1303 (2009)
27. Taylor, C.B., Houston-Miller, N., Killen, J.D., DeBusk, R.F.: Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Ann. Intern. Med. 113(2), 118–123 (1990)
28. Huttunen-Lenz, M., Song, F., Poland, F.: Are psychoeducational smoking cessation interventions for coronary heart disease patients effective? Meta-analysis of interventions. Br. J. Health Psychol. 15(4), 749–777 (2010)
29. Rigotti, N.A., Clair, C., Munafò, M.R., Stead, L.F.: Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst. Rev. 5, CD001837 (2012). doi:10.1002/14651858.CD001837.pub3
30. Stead, L.F., Lancaster, T.: Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst. Rev. 10, CD008286 (2012). doi:10.1002/14651858.CD008286.pub2
31. Krumholz, H.M., Cohen, B.J., Tsevat, J., Pasternak, R.C., Weinstein, M.C.: Cost-effectiveness of a smoking cessation program after myocardial infarction. J. Am. Coll. Cardiol. 22(6), 1697–1702 (1993)
32. Quist-Paulsen, P., Lydersen, S., Bakke, P.S., Gallefoss, F.: Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease. Eur. J. Cardiovasc. Prev. Rehabil. 13(2), 274–280 (2006)
33. Lapado, J.A., Jaffer, F.A., Weinstein, M.C., Froelicher, E.S.: Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction. Arch. Intern. Med. 171(1), 39–45 (2011)
34. Lichtenstein, E., Glasgow, R.E., Lando, H.A., Ossip-Klein, D.J., Boles, S.M.: Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence. Health Educ. Res. 11(2), 243–257 (1996)
35. Reese, R.J., Conoley, C.W., Brossart, D.F.: The attractiveness of telephone counseling: an empirical investigation of client perceptions. J. Couns. Dev. 84(1), 54–60 (2006)
36. Central Committee on Research Involving Human Subjects (Centrale Commissie Mensgebonden Onderzoek (CCMO)): the review system in the Netherlands. http://www.ccmo.nl/en/ (2010). Accessed 12 May 2010
37. World Health Organization (WHO): International statistical classification of diseases and related health problems. 10th revision. WHO, Geneva (2010). http://www.who.int/classifications/icd/en/. Accessed 21 Sept 2010
38. Hubbard, R., Lewis, S., Smith, C., Godfrey, C., Smeeth, L., Farrington, P., Britton, J.: Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob. Control 14(6), 416–421 (2005)
39. Meine, T.J., Patel, M.R., Washam, J.B., Pappas, P.A., Jollis, J.G.: Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am. J. Cardiol. 95(8), 976–978 (2005)
40. Hughes, J.R., Stead, L.F., Hartmann-Boyce, J., Cahill, K., Lancaster, T.: Antidepressants for smoking cessation. Cochrane Database Syst. Rev. 1, 031 (2014). doi:10.1002/14651858.031.pub4
41. Stead, L.F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., Lancaster, T.: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 11, 146 (2012). doi:10.1002/14651858.146.pub4
42. Silagy, C., Lancaster, T., Stead, L., Mant, D., Fowler, G.: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. (3), 146 (2004). doi:10.1002/14651858.146.pub2
43. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerstroem, K.O.: The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br. J. Addict. 86(9), 1119–1127 (1991)
44. Mudde, A.N., Willemsen, M.C., Kremers, S., de Vries, H.: Meetinstrumenten voor onderzoek naar roken en stoppen met roken. Dutch Expert Center for Tobacco Control, the Hague (2006)
45. De Vries, H., Mudde, A., Leijs, I., Charlton, A., Vartiainen, E., Buijs, G., et al.: The European Smoking Prevention Framework Approach (EFSA): an example of integral prevention. Health Educ. Res. 18(5), 611–626 (2003)
46. De Vries, H., Mesters, I., van der Steeg, H., Honing, C.: The general public’s information needs and perceptions regarding hereditary cancer: an application of the integrated change model. Patient Educ. Couns. 56(2), 154–165 (2005)
47. Fishbein, M., Ajzen, I.: Predicting and changing behavior: the reasoned action approach. Psychology Press, Taylor and Francis Group, New York (2010)
48. Prochaska, J.O., DiClemente, C.C.: Stages and processes of self-change of smoking: toward an integrative model of change. J. Consult. Clin. Psychol. 51(3), 390–395 (1983)
49. Hakkaart-van Roijen, L., Tan, S.S., Bouwmans, C.A.M.: Handleiding voor kostenonderzoek: methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. College voor Zorgverzekeringen, Rotterdam (2010)
50. College voor Zorgverzekeringen: Guidelines for pharmaco–economic research, updated version. College voor Zorgverzekeringen, Diemen (2006)
51. Hassan, E.: Recall bias can be a threat to retrospective and prospective research designs. Internet J. Epidemiol. 3(2), p4 (2006)
52. Manca, A., Palmer, S.: Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Appl. Health Econ. Health Policy 4(2), 65–75 (2005)
53. Burton, A., Billingham, L.J., Bryan, S.: Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data. Clin. Trials 4(2), 154–161 (2007)
54. Oostenbrink, J.B., Al, M.J.: The analysis of incomplete cost data due to dropout. Health Econ. 14(8), 763–776 (2005)
55. Hendriks, M.R., Al, M.J., Bleijlevens, M.H., van Haastregt, J.C., Crebolder, H.F., van Eijk, J.T., Evers, S.M.: Continuous versus discontinuous measurement of healthcare utilization. Med. Dec. Making 33(8), 998–1008 (2013)
56. College voor Zorgverzekeringen: Farmacotherapeutisch kompas: medicijnkosten. College voor Zorgverzekeringen, Diemen (2012). http://www.medicijnkosten.nl/. Accessed 09 Jan 2011
57. Koopmanschap, M., Meerding, W.J., Evers, S.M., Severens, H., Burdorf, A., Brouwer, W.: Manual for the use of the PRODISQ version 2.1. Erasmus MC. Institute of Medical Technology Assessment, Rotterdam (2004)
58. Velicer, W.F., Prochaska, J.O.: A comparison of four self-report smoking cessation outcome measures. Addict. Behav. 29(1), 51–60 (2004)
59. Drummond, M.F.: Introducing economic and quality of life measurements into clinical studies. Ann. Med. 33(5), 344–349 (2001)
60. Drummond, M.F., O’Brien, B.J., Sculpher, M.J., Thorrance, G.W., Stoddart, G.L.: Methods for the economic evaluation of health care programmes (3rd revised edn). Oxford University Press, Oxford (2005)
61. EuroQol Group: EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16(3), 199–208 (1990)
62. Lamers, L.M., McDonnell, J., Stalmeier, P.F., Krabbe, P.F., Busschbach, J.J.: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 15(10), 1121–1132 (2006)
63. Manca, A., Hawkins, N., Sculpher, M.J.: Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 14(5), 487–496 (2005)
64. Centraal Bureau voor Statistiek: Overview of consumer price indexes. Centraal Bureau voor Statistiek, Heerlen (2011). http://statline.cbs.nl/statweb/. Accessed 12 Jan 2011
65. Sendi, P.P., Briggs, A.H.: Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane. Health Econ. 10(7), 675–680 (2001)
66. Fenwick, E., O’Brien, B.J., Briggs, A.: Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ. 13(5), 405–415 (2004)
67. Boersma, C., Broere, A., Postma, M.J.: Quantification of the potential impact of cost-effectiveness thresholds on Dutch drug expenditures using retrospective analysis. Value Health 13(6), 853–856 (2010)
68. Raad voor de Volksgezondheid en Zorg: Zinnige en duurzame zorg: transparante keuzen in de zorg voor een houdbaar zorgstelsel. Raad voor de Volksgezondheid en Zorg, Zoetermeer (2006)
69. Smit, E.S., Evers, S.M., de Vries, H., Hoving, C.: Cost-effectiveness and cost-utility of internet-based computer-tailoring for smoking cessation: a trial-based economic evaluation among Dutch adult smokers. J. Med. Internet Res. 15(3), e57 (2013). doi:10.2196/jmir.2059
70. Stanczyk, N.E., Smit, E.S., Schulz, D.N., de Vries, H., Bolman, C., Muris, J.W.M., Evers, S.M.A.A.: An economic evaluation of a video and text-based computer-tailored intervention for smoking cessation: a cost-effectiveness and cost-utility analysis of a randomized controlled trial. PLoS One 9(10), e110117 (2014)
71. Schulz, D.N., Smit, E.S., Stanczyk, N.E., Kremers, S.P.J., de Vries, H., Evers, S.M.A.A.: Economic evaluation of a web-based tailored lifestyle intervention for adults: findings regarding cost-effectiveness and cost–utility from a randomized controlled trial. J. Med. Internet Res. 16(3), e91 (2014)
72. Golsteijn, R.H.J., Peels, D.A., Evers, S.M.A.A., Bolman, C., Mudde, A.N., de Vries, H., Lechner, L.: Cost-effectiveness and cost–utility of a web-based or print-delivered tailored intervention to promote physical activity among adults aged over fifty: an economic evaluation of the active plus intervention. Int. J. Behav. Nutr. Phys. Act. 11(122) (2014)
73. Stinnett, A.A., Mullahy, J.: Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med. Decis. Making 18(2 Suppl), S68–S80 (1998)
74. Feenstra, T.L., Hamberg-van Reenen, H.H., Hoogenveen, R.T., Rutten-van Molken, M.P.: Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health 8(3), 178–190 (2005)
75. Feenstra, T.L., van Baal, P.H.M., Hoogenveen, R.T., Vijgen, S.M.C., Stolk, E., Bemelmans, W.J.E.: Cost-effectiveness of interventions to reduce tobacco smoking in the Netherlands. An application of the RIVM chronic disease model. RIVM rapport 260601003/2005. RIVM, Bilthoven (2005)
76. Christenhusz, L.C., Prenger, R., Pieterse, M.E., Seydel, E.R., van der Palen, J.: Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients. Nicot. Tob. Res. 14(6), 657–663 (2012)
77. Wiggers, L.C., Oort, F.J., Peters, R.J., Legemate, D.A., de Haes, H.C., Smets, E.M.: Smoking cessation may not improve quality of life in atherosclerotic patients. Nicot. Tob. Res. 8(4), 581–589 (2006)
78. Knies, S., Evers, S.M., Candel, M.J., Severens, J.L., Ament, A.J.: Utilities of the EQ-5D: transferable or not? Pharmacoeconomics 27(9), 767–779 (2009)
79. Goldsmith, K.A., Dyer, M.T., Schofield, P.M., Buxton, M.J., Sharples, L.D.: Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions. Health Qual. Life Outcomes 7(96) (2009). doi:10.1186/1477-7525-7-96
80. Moock, J., Kohlmann, T.: Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Qual. Life Res. 17(3), 485–495 (2008)
81. Marlatt, G.A., Donovan, D.M.: Relapse prevention: maintenance strategies in the treatment of addictive behaviors. The Guilford Press, New York (2005)
82. Hughes, J.R., Peters, E.N., Naud, S.: Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict. Behav. 33(12), 1516–1520 (2008)
83. US Department of Health and Human Services: The health benefits of smoking cessation. A report of the US Surgeon General. Centers for Disease Control, Office on Smoking and Health, Rockville (1990)
84. Anthonisen, N.R., Connett, J.E., Kiley, J.P., Altose, M.D., Bailey, W.C., Buist, A.S., Conway, W.A., Enright, P.L., et al.: Effects of smoking intervention and the use of an inhaled, anticholinergic bronchodilator on the rate of decline of FEV1. JAMA 272(19), 1497–1505 (1994)
85. Gorber, S.C., Schofield-Hurwitz, S., Hardt, J., Levasseur, G., Tremblay, M.: The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicot. Tob. Res. 11(1), 12–24 (2009)